Entries from October 2024

New sunscreen candidate, tirzepatide is back, flu infection protection, and more

Published October 5, 2024

GLP-1s may not be so great, CVS could split, AI for pharma students, and more

Published October 3, 2024

EPA must reconsider fluoride, type-1 diabetes cured (maybe), pharmacist prescribing goes mainstream-er, and more

Published October 1, 2024